Literature DB >> 21365058

Is Tayside becoming a Scottish hotspot for Lyme borreliosis?

G S Slack1, S Mavin, D Yirrell, D O Ho-Yen.   

Abstract

The epidemiology of Lyme borreliosis (LB) in Tayside was studied and compared with Highland (an area of high endemicity) and the rest of Scotland. From April 2001 to March 2008 the incidence of LB in Tayside rose from an estimated 2.57 to 5.84 per 100,000 population. In 2008/09 the incidence of LB in Tayside increased further to an estimated 13.85 per 100,000 population. This rise was significant and, although numerically less than that in Highland (37.24 to 49.69 per 100,000 population), it was proportionally much larger (137% vs 33%) and confirmed that LB in Tayside has diverged from that in non-endemic Scottish regions. The dramatic rise of LB in Tayside cannot be accounted for by changes in laboratory protocol or changes in the number or demographics of patients tested. However, changes in climatic conditions and alterations in clinical presentations may have contributed to this significant rise.

Entities:  

Mesh:

Year:  2011        PMID: 21365058     DOI: 10.4997/JRCPE.2011.102

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN: 1478-2715


  3 in total

1.  Modelling the seasonality of Lyme disease risk and the potential impacts of a warming climate within the heterogeneous landscapes of Scotland.

Authors:  Sen Li; Lucy Gilbert; Paula A Harrison; Mark D A Rounsevell
Journal:  J R Soc Interface       Date:  2016-03       Impact factor: 4.118

Review 2.  Brave New Worlds: The Expanding Universe of Lyme Disease.

Authors:  Brandee L Stone; Yvonne Tourand; Catherine A Brissette
Journal:  Vector Borne Zoonotic Dis       Date:  2017-07-20       Impact factor: 2.133

3.  Emergence of Lyme Disease on Treeless Islands, Scotland, United Kingdom.

Authors:  Caroline Millins; Walter Leo; Isabell MacInnes; Johanne Ferguson; Graham Charlesworth; Donald Nayar; Reece Davison; Jonathan Yardley; Elizabeth Kilbride; Selene Huntley; Lucy Gilbert; Mafalda Viana; Paul Johnson; Roman Biek
Journal:  Emerg Infect Dis       Date:  2021-02       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.